LONDON MARKET CLOSE: FTSE 100 drifts lower as oil price pushes higher
(Alliance News) - Stocks in London closed in the red on Monday, with fresh gains in the oil price and a lack of new catalysts curbing enthusiasm. Read More
| Price | 1,851.50p on 17-08-2026 at 18:35:07 |
|---|---|
| Change | 34.00p 1.87% |
| Buy | 1,855.50p |
| Sell | 1,854.50p |
| Last Trade: | Sell 8.00 at 1,851.50p |
| Day's Volume: | 3,968,556 |
| Last Close: | 1,851.50p |
| Open: | 1,829.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,829.00p - 1,859.00p |
| 52wk Range: | 1,430.00p - 2,282.00p |
| Market Capitalisation: | £74.16b |
| VWAP: | 1,843.99087p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 8 | 1,851.50p | SI Trade |
16:38:58 - 17-Aug-26 |
| Sell* | 57 | 1,851.50p | SI Trade |
16:37:09 - 17-Aug-26 |
| Sell* | 136 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
| Sell* | 20 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
| Sell* | 1,233 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
| Sell* | 2,825 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
| Sell* | 2,589 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
| Sell* | 1,306 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
| Sell* | 1,054 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
| Sell* | 217 | 1,851.50p | SI Trade |
16:35:10 - 17-Aug-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Aug 2026 3:33 pm | RNS | Director/PDMR Shareholding |
| 11th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 3:00 pm | RNS | Total Voting Rights |
| 30th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Jul 2026 12:05 pm | RNS | New GSK flagship R&D centre in Cambridge |
| 28th Jul 2026 12:00 pm | RNS | 2nd Quarter Results |
| 28th Jul 2026 11:06 am | RNS | Hansoh positive 2nd Phase III results for Riz-Rez |
| 24th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Jul 2026 3:00 pm | RNS | Admission to Trading |
| 22nd Jul 2026 5:22 pm | RNS | Jideytro approved in US for certain lung cancers |